Infectious Diseases News and Research

RSS

Hunterdon Medical Center uses LightStrike robot to quickly zap away pathogens

As germs and bacteria become increasingly resistant to cleaning chemicals and antibiotics, Hunterdon Medical Center recently deployed Xenex LightStrike Germ-Zapping Robots that use pulsed xenon ultraviolet light to enhance traditional room cleaning procedures as a key part of the hospital's infection prevention program.

10 Sep 2018

Researchers begin trial to reduce risks of major cause of childhood disabilities

Researchers are beginning recruitment in a trial to see if changing pregnant women's hygiene habits could reduce the risks of a major cause of childhood disabilities.

7 Sep 2018

UNC and Cell Microsystems receive NIH Phase I SBIR contract to develop HIV diagnostic assay

The University of North Carolina at Chapel Hill HIV Cure Center and Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced they have received an approximately $283,000, 12-month Phase I Small Business Innovation and Research contract from the National Institutes of Health to develop an automated platform to quantify the latent HIV reservoir.

7 Sep 2018

Telehealth videoconferencing promotes antibiotic stewardship efforts in rural facilities

A pilot project at two rural VA medical centers demonstrated that telehealth videoconferencing promoted antibiotic stewardship efforts by linking remote facilities to infectious diseases-trained professionals, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

6 Sep 2018

Global warming may increase likelihood of HFMD transmission

Hand, foot, and mouth disease is a common childhood viral infection that is most common in warmer summer months.

6 Sep 2018

Phase 1 clinical trial examining topical cream plus influenza vaccine is underway

A Phase 1 clinical trial examining whether a topical cream can enhance the immune response conferred by a "pre-pandemic" influenza vaccine is underway at Baylor College of Medicine in Houston.

6 Sep 2018

Airport security trays carry more microbes than toilet seats

A team of researchers from Finland and Britain have shown that over half of all the trays or security bins that the airport authorities use at the security clearance areas carry viruses that can cause respiratory infections.

6 Sep 2018

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Many of the vaccines critically needed to fight some of the world's most prevalent infectious diseases are not likely to be developed, a new analysis of current candidates in the research and development pipeline has found.

5 Sep 2018

Scientists receive $2.5 million grant to combat South American-borne deadly disease

A George Mason University researcher is heading a scientific team that has received a sizable Department of Defense grant to combat the threat of a South American-borne disease that can cause long-term neurological problems and even death.

5 Sep 2018

Mouse models may not completely reflect severity of gonorrhea infection

There is an urgent need to develop a vaccine to prevent gonorrhea infection due to rapidly increasing incidence and growing antibiotic resistance.

4 Sep 2018

New project aims to combat drug-resistant bacteria in hospitals

Antibiotic resistance is a big global public health problem. Of particular concern are multidrug-resistant Gram-negative bacteria, which are among the leading causes of serious, debilitating and life threatening healthcare-associated infections.

3 Sep 2018

Study provides insights into how harmful white blood cells form during tuberculosis

Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

31 Aug 2018

Groundbreaking CURATE.AI platform halts progression of advanced cancer

A translational research team led by the National University of Singapore has harnessed CURATE.AI, a powerful artificial intelligence platform, to successfully treat a patient with advanced cancer, completely halting disease progression.

31 Aug 2018

NUS researchers harness AI platform to treat patient with advanced cancer

31 Aug 2018

Newborns require special diagnosis and treatment considerations for C. difficile infection

Newborns require special diagnosis and treatment considerations for an infectious diarrhea known as Clostridioides difficile infection, according to a new evidence-based white paper published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

31 Aug 2018

Simple intervention increases use of HIV medications in injection-drug users

A relatively simple effort to provide counseling and connect injection-drug users with resources could prove powerful against the spread of HIV in a notoriously hard-to-reach population, new research suggests.

31 Aug 2018

TGHRI scientists detail role of insulin as a boost to the immune system

The role of insulin as a boost to the immune system to improve its ability to fight infection has been detailed for the first time by Toronto General Hospital Research Institute scientists.

30 Aug 2018

Immunization shots effective at preventing measles

High fever. Cough. Runny nose. Red, watery eyes. It may not be the flu. It could be measles.

30 Aug 2018

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.

30 Aug 2018

UH researchers win $3.5 million grant to develop technology that combats multi-drug resistant bacteria

Two UH researchers have won a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases to develop technology that will quickly suggest the most promising combinations of antibiotics to kill certain resistant bacteria.

30 Aug 2018

Infectious Diseases News and Research

Hunterdon Medical Center uses LightStrike robot to quickly zap away pathogens

Researchers begin trial to reduce risks of major cause of childhood disabilities

UNC and Cell Microsystems receive NIH Phase I SBIR contract to develop HIV diagnostic assay

Telehealth videoconferencing promotes antibiotic stewardship efforts in rural facilities

Global warming may increase likelihood of HFMD transmission

Phase 1 clinical trial examining topical cream plus influenza vaccine is underway

Airport security trays carry more microbes than toilet seats

Effective vaccines for world's most prevalent infectious diseases are missing from pipeline

Scientists receive $2.5 million grant to combat South American-borne deadly disease

Mouse models may not completely reflect severity of gonorrhea infection

New project aims to combat drug-resistant bacteria in hospitals

Study provides insights into how harmful white blood cells form during tuberculosis

Groundbreaking CURATE.AI platform halts progression of advanced cancer

NUS researchers harness AI platform to treat patient with advanced cancer

Newborns require special diagnosis and treatment considerations for C. difficile infection

Simple intervention increases use of HIV medications in injection-drug users

TGHRI scientists detail role of insulin as a boost to the immune system

Immunization shots effective at preventing measles

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

UH researchers win $3.5 million grant to develop technology that combats multi-drug resistant bacteria

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News